Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengshang Xiaotong Plaster (正伤消痛膏) is a marketed Traditional Chinese Medicine (TCM) topical formulation developed and manufactured by Xi'an Qianhe Pharmaceutical. It is indicated for the relief of pain and swelling associated with traumatic injuries, such as bruises, sprains, and musculoskeletal aches. As a topical plaster, it is applied directly to the skin over the affected area to deliver herbal active ingredients. In the context of Traditional Chinese Medicine, the formulation is designed to promote blood circulation, resolve blood stasis, and reduce inflammation. It is one of the core marketed products of Xi'an Qianhe Pharmaceutical, a company known for its focus on standardized TCM production and GMP-certified facilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhengshang Xiaotong Plaster.